A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
Key facts
- Where
- Ahaus, Augsburg, Bad Camberg, Biberach an der Riss, Bramsche, Chemnitz, Gera, Gladbeck, Halle, Haßfurt, Karlsruhe, Kelheim, Kulmbach, Leipzig, Mainz, Merzig, Mönchengladbach, Remscheid, Schwelm, Wasserburg A. Inn, and Wiesbaden, GermanySee the 21 sites
Where in Germany
- Hautarztliche Gemeinschaftspraxis Dres. med. Petri & Mocklinghoff /ID# 279230Ahaus, GermanyContact: Beth RycroftTaking people
- Private Practice - Dr. Virgil Oreste Mihaescu /ID# 279229Augsburg, GermanyContact: Beth RycroftTaking people
- MVZ medicum.mittelhessen /ID# 279136Bad Camberg, GermanyContact: Beth RycroftTaking people
- Mvz Corius Biberach Gmbh /Id# 281157Biberach an der Riss, GermanyContact: Beth RycroftTaking people
- Studienzentrum an der Hase GbR Dr. Weyergraf/Dr. Frick/Thomas Heiber /ID# 279210Bramsche, GermanyContact: Beth RycroftTaking people
- Private Practice - Dr. Petra Hausler-Mehlhorn /ID# 280434Chemnitz, GermanyContact: Beth RycroftTaking people
- Private Practice - Dr. Dirk Lange /ID# 279215Gera, GermanyContact: Beth RycroftTaking people
- Hautarztpraxis Shirin Samimi-Fard & Elena Dippel /ID# 279232Gladbeck, GermanyContact: Beth RycroftTaking people
- Private Practice - Dr. Abdou Zarzour /ID# 279125Halle, GermanyContact: Beth RycroftTaking people
- Hautarztpraxis Hassberge Dr. Boris Bauer /ID# 279272Haßfurt, GermanyContact: Beth RycroftTaking people
- Derma Sana /ID# 279254Karlsruhe, GermanyContact: Beth RycroftTaking people
- Dr. Neumann /ID# 279255Kelheim, GermanyContact: Beth RycroftTaking people
- Dermakulm /Id# 279126Kulmbach, GermanyContact: Beth RycroftTaking people
- Hautarztpraxis Dr. Med. Ulrike Wiemers / Dr. Med. Franca Wiemers /ID# 279124Leipzig, GermanyContact: Beth RycroftTaking people
- Dermatologie Quist-BAG Dres. med. Quist PartG /ID# 279271Mainz, GermanyContact: Beth RycroftTaking people
- HMS GmbH Zimmer /ID# 279211Merzig, GermanyContact: Beth RycroftTaking people
- ZENTderma /ID# 279235Mönchengladbach, GermanyContact: Beth RycroftTaking people
- Private Practice - Dr. Dariusch Mortazawi /ID# 279214Remscheid, GermanyContact: Beth RycroftTaking people
- Hautarztpraxis Schwelm /ID# 279140Schwelm, GermanyContact: Beth RycroftTaking people
- Praxis Dehmel / Brand-Opitzer /ID# 279351Wasserburg A. Inn, GermanyContact: Beth RycroftTaking people
- Dr. med. Nicola Möller & Thomas Kurtenbach GbR Dermatologie im Zentrum /ID# 279137Wiesbaden, GermanyContact: Beth RycroftTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- AbbVie
- Trial code
- NCT07136467
- Record updated
- 13 February 2026
- Original description
This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population.Read full original descriptionShow less
Multi-Country, Cross-sectional Study to Characterize Real World Burden of Disease in Adolescent and Adult Patients With Alopecia Areata, Vitiligo or Hidradenitis Suppurativa (MEASURE AAVitHS)
This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population.
Inclusion: Participants with Physician-confirmed diagnosis of non-segmental vitiligo (NSV), moderate to severe Alopecia Areata (AA), or moderate to severe hidradenitis suppurativa (HS); Participants Ability to understand study questionnaires, with caregiver support as required for adolescents.
Exclusion: Participating in interventional clinical trial(s) at time of study visit (participation in another non-interventional study or registry does not exclude a participant from this study); Unable or unwilling to comply with study requirements and PRO collection.